The Mobile Non-Invasive Ventilation industry trends over the past 18 months have been shaped by rapid innovation and strategic collaborations. Key players like ResMed and Philips have partnered with telehealth platforms to integrate remote patient monitoring systems, enhancing home-based care solutions. Air Liquide expanded its footprint through the acquisition of a European-based MVN device manufacturer, signaling a focus on diversified product portfolios. In early 2023, Fisher & Paykel launched a portable ventilator with AI-driven adaptive pressure support, addressing growing demand for user-friendly, compact devices. Regulatory shifts, such as the FDA’s updated guidelines for ventilator safety standards, have also spurred product redesigns and accelerated approvals. Notably, consumer preference has tilted toward devices offering dual CPAP/ventilation modes, driven by rising home healthcare adoption. Breas Medical secured a $50M Series C round in 2024 to scale its mobile ventilation systems, reflecting investor confidence in market potential. These developments underscore a sector prioritizing technology integration, regulatory compliance, and flexible patient-centric solutions.
